Home > Food & Beverages > Nutraceuticals > Herbal Supplements > Serrata Extract Market

Serrata Extract Market Analysis

  • Report ID: GMI5357
  • Published Date: Sep 2022
  • Report Format: PDF

Serrata Extract Market Analysis

Global serrata extract market is divided into powder and liquid segments based on product form. The powder form category is expected to grow at a CAGR of more than 10% through 2030. Powdered products are considered to be less expensive and easier to administer, resulting in higher patient compliance. Through powdered form, small dosage is needed and can be consumed entirely without any wastage. The cost benefit of producing serrata extract powder will complement segment growth.

In terms of application, the serrata extract market is divided into four categories – herbal medicines, food supplements, aromatherapy, and others. The herbal medicine segment held notable industry share in the recent past and is estimated to account for more than USD 65 million by 2030. Ancient societies in nations such as India, China, South America, and Egypt continue to rely on plant-based therapies to manage serious health conditions. Furthermore, there is a burgeoning scientific and economic interest in medicinal plants as raw materials among herbal pharmaceutical firms. The increased acceptance of herbal treatments is bolstering the demand for serrata extract, aiding the industry expansion.

Regionally, the APAC segment is predicted to grow unprecedently due to the prevalence of leading pharma companies in the region. The regulatory relaxations associated with the product use will also foster the demand for serrata extract. Notably, Southeast Asia and South Asia are green grounds for medicinal plants used in traditional medicine. Boswellia serrata, the plant which is native to much of India and the Punjab area that stretches into Pakistan, has been utilized for numerous ayurvedic compositions since ancient times. To that effect, the Asia Pacific serrata extract market is anticipated to be worth more than USD 58 million by 2030.

Authors: Kiran Pulidindi

Frequently Asked Questions (FAQ) :

The size of serrata extract industry was worth over USD 85 million in 2021 and it is anticipated to grow at a CAGR of 10.5% during the forecast period 2022-2030, owing to widespread acceptance of herbal medicines.

Asia Pacific market is estimated to be valued over 58 million by 2030, backed by the prevalence of leading pharma companies in the region and the regulatory relaxations associated with the product use.

The powder segment is expected to grow at a CAGR of more than 10% through 2030, pertaining to benefits like easy administration, small dosage, and cost-effective production.

The key manufacturers of serrata extract include Manus Aktteva biopharma LLP, Marven Bio Chem, Hernal BioActives LLP, Sanat, S.A, Jayshree Nath Herbals, Alps Pure, IFF Health (Frutarom Health), Now Food, Arjuna Natural, Alchem International, Bioprex Labs, Himalayan Herbaria, and others.

Serrata Extract Market Scope

Buy Now

Premium Report Details

  • Base Year: 2021
  • Companies covered: 16
  • Tables & Figures: 138
  • Countries covered: 14
  • Pages: 150
 Download Free Sample